Company Filing History:
1 out of 5,111 
1 out of 1,835 
1 out of 20 Years Active: 2022
Title: Oleksandr Grytsai: Innovator in Cancer Treatment
Introduction
Oleksandr Grytsai is a notable inventor based in Nice, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the creation of biguanide derivatives, which hold promise in the fight against cancer, particularly melanoma.
Latest Patents
Grytsai holds a patent for "Biguanide derivatives and their rearrangement products for use in the treatment of cancer." This patent describes biguanide derivatives of formula (I) and their rearrangement products. The compounds outlined in this patent are intended for use in methods for treating cancer, specifically targeting melanoma.
Career Highlights
Throughout his career, Oleksandr Grytsai has worked with prestigious research institutions, including the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Grytsai has collaborated with esteemed colleagues such as Rachid Benhida and Stephane Rocchi. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in cancer treatment.
Conclusion
Oleksandr Grytsai's work in developing biguanide derivatives represents a significant advancement in cancer treatment. His contributions to the field, along with his collaborations, highlight the importance of innovation in medical research.